nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—SLCO1B3—Liothyronine—hypothyroidism	0.106	0.133	CbGbCtD
Losartan—SLCO1B3—Levothyroxine—hypothyroidism	0.106	0.133	CbGbCtD
Losartan—SLCO1B3—Liotrix—hypothyroidism	0.103	0.13	CbGbCtD
Losartan—SLCO1B1—Dextrothyroxine—hypothyroidism	0.0812	0.102	CbGbCtD
Losartan—SLCO1B1—Liothyronine—hypothyroidism	0.0615	0.0775	CbGbCtD
Losartan—SLCO1B1—Levothyroxine—hypothyroidism	0.0615	0.0775	CbGbCtD
Losartan—SLCO1B1—Liotrix—hypothyroidism	0.0601	0.0757	CbGbCtD
Losartan—ALB—Liothyronine—hypothyroidism	0.0337	0.0425	CbGbCtD
Losartan—ALB—Levothyroxine—hypothyroidism	0.0337	0.0425	CbGbCtD
Losartan—ALB—Liotrix—hypothyroidism	0.0329	0.0414	CbGbCtD
Losartan—CYP2C8—Levothyroxine—hypothyroidism	0.026	0.0328	CbGbCtD
Losartan—CYP2C8—Liotrix—hypothyroidism	0.0254	0.032	CbGbCtD
Losartan—ABCB1—Levothyroxine—hypothyroidism	0.0176	0.0222	CbGbCtD
Losartan—ABCB1—Liothyronine—hypothyroidism	0.0176	0.0222	CbGbCtD
Losartan—ABCB1—Liotrix—hypothyroidism	0.0172	0.0217	CbGbCtD
Losartan—CYP3A4—Levothyroxine—hypothyroidism	0.0106	0.0133	CbGbCtD
Losartan—UGT1A1—urine—hypothyroidism	0.00436	0.0658	CbGeAlD
Losartan—Gastric irritation—Liotrix—hypothyroidism	0.00384	0.0367	CcSEcCtD
Losartan—UGT2B17—liver—hypothyroidism	0.00335	0.0506	CbGeAlD
Losartan—Epigastric discomfort—Liotrix—hypothyroidism	0.00283	0.0271	CcSEcCtD
Losartan—ACE—urine—hypothyroidism	0.00281	0.0424	CbGeAlD
Losartan—SLC2A9—heart—hypothyroidism	0.00254	0.0384	CbGeAlD
Losartan—Angina pectoris—Liothyronine—hypothyroidism	0.00252	0.0241	CcSEcCtD
Losartan—CYP2C19—urine—hypothyroidism	0.00236	0.0357	CbGeAlD
Losartan—ACE—nerve—hypothyroidism	0.00194	0.0293	CbGeAlD
Losartan—CYP1A2—urine—hypothyroidism	0.00193	0.0291	CbGeAlD
Losartan—SLC2A9—adrenal gland—hypothyroidism	0.0019	0.0287	CbGeAlD
Losartan—SLC2A9—blood—hypothyroidism	0.0019	0.0286	CbGeAlD
Losartan—UGT1A10—liver—hypothyroidism	0.00189	0.0286	CbGeAlD
Losartan—Arrhythmia—Liothyronine—hypothyroidism	0.00185	0.0177	CcSEcCtD
Losartan—CYP2C9—urine—hypothyroidism	0.00183	0.0277	CbGeAlD
Losartan—SLC2A9—thyroid gland—hypothyroidism	0.00183	0.0276	CbGeAlD
Losartan—SLC2A9—female gonad—hypothyroidism	0.00177	0.0267	CbGeAlD
Losartan—Cellulitis—Liotrix—hypothyroidism	0.00164	0.0157	CcSEcCtD
Losartan—SLC2A9—testis—hypothyroidism	0.00157	0.0237	CbGeAlD
Losartan—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00151	0.0144	CcSEcCtD
Losartan—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00151	0.0144	CcSEcCtD
Losartan—SLC2A9—liver—hypothyroidism	0.00148	0.0224	CbGeAlD
Losartan—Tachycardia—Liothyronine—hypothyroidism	0.00144	0.0137	CcSEcCtD
Losartan—Blood urea increased—Liotrix—hypothyroidism	0.00141	0.0134	CcSEcCtD
Losartan—CYP3A4—urine—hypothyroidism	0.0014	0.0211	CbGeAlD
Losartan—Hypotension—Liothyronine—hypothyroidism	0.00137	0.0131	CcSEcCtD
Losartan—SLCO1B3—pituitary gland—hypothyroidism	0.00134	0.0203	CbGeAlD
Losartan—UGT1A3—liver—hypothyroidism	0.00133	0.0201	CbGeAlD
Losartan—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0013	0.0124	CcSEcCtD
Losartan—Muscular weakness—Levothyroxine—hypothyroidism	0.0013	0.0124	CcSEcCtD
Losartan—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00124	0.0118	CcSEcCtD
Losartan—Angina pectoris—Levothyroxine—hypothyroidism	0.00124	0.0118	CcSEcCtD
Losartan—Swelling—Liotrix—hypothyroidism	0.00123	0.0117	CcSEcCtD
Losartan—Body temperature increased—Liothyronine—hypothyroidism	0.00116	0.0111	CcSEcCtD
Losartan—Renal impairment—Liotrix—hypothyroidism	0.00114	0.0109	CcSEcCtD
Losartan—Hypoglycaemia—Liotrix—hypothyroidism	0.00111	0.0106	CcSEcCtD
Losartan—Sweating—Levothyroxine—hypothyroidism	0.00109	0.0104	CcSEcCtD
Losartan—Sweating—Dextrothyroxine—hypothyroidism	0.00109	0.0104	CcSEcCtD
Losartan—Blood creatinine increased—Liotrix—hypothyroidism	0.00101	0.00969	CcSEcCtD
Losartan—AGTR1—adrenal cortex—hypothyroidism	0.00101	0.0152	CbGeAlD
Losartan—AGTR1—heart—hypothyroidism	0.000974	0.0147	CbGeAlD
Losartan—Muscular weakness—Liotrix—hypothyroidism	0.000953	0.00912	CcSEcCtD
Losartan—Flushing—Levothyroxine—hypothyroidism	0.000943	0.00902	CcSEcCtD
Losartan—Flushing—Dextrothyroxine—hypothyroidism	0.000943	0.00902	CcSEcCtD
Losartan—SLCO1B3—liver—hypothyroidism	0.000937	0.0142	CbGeAlD
Losartan—AGTR1—cardiovascular system—hypothyroidism	0.000919	0.0139	CbGeAlD
Losartan—Angina pectoris—Liotrix—hypothyroidism	0.00091	0.00871	CcSEcCtD
Losartan—Arrhythmia—Levothyroxine—hypothyroidism	0.000908	0.00869	CcSEcCtD
Losartan—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000908	0.00869	CcSEcCtD
Losartan—Bronchitis—Liotrix—hypothyroidism	0.000898	0.00859	CcSEcCtD
Losartan—Alopecia—Levothyroxine—hypothyroidism	0.000898	0.00859	CcSEcCtD
Losartan—Alopecia—Dextrothyroxine—hypothyroidism	0.000898	0.00859	CcSEcCtD
Losartan—Tension—Dextrothyroxine—hypothyroidism	0.000868	0.00831	CcSEcCtD
Losartan—Tension—Levothyroxine—hypothyroidism	0.000868	0.00831	CcSEcCtD
Losartan—Nervousness—Levothyroxine—hypothyroidism	0.000859	0.00822	CcSEcCtD
Losartan—Nervousness—Dextrothyroxine—hypothyroidism	0.000859	0.00822	CcSEcCtD
Losartan—UGT1A1—blood—hypothyroidism	0.000833	0.0126	CbGeAlD
Losartan—Tremor—Dextrothyroxine—hypothyroidism	0.000829	0.00793	CcSEcCtD
Losartan—Tremor—Levothyroxine—hypothyroidism	0.000829	0.00793	CcSEcCtD
Losartan—Renal failure—Liotrix—hypothyroidism	0.000819	0.00783	CcSEcCtD
Losartan—AGTR1—pituitary gland—hypothyroidism	0.000814	0.0123	CbGeAlD
Losartan—Agitation—Dextrothyroxine—hypothyroidism	0.000813	0.00778	CcSEcCtD
Losartan—Agitation—Levothyroxine—hypothyroidism	0.000813	0.00778	CcSEcCtD
Losartan—UGT2B7—testis—hypothyroidism	0.000811	0.0122	CbGeAlD
Losartan—Angioedema—Dextrothyroxine—hypothyroidism	0.000809	0.00773	CcSEcCtD
Losartan—Angioedema—Levothyroxine—hypothyroidism	0.000809	0.00773	CcSEcCtD
Losartan—Sweating—Liotrix—hypothyroidism	0.000798	0.00764	CcSEcCtD
Losartan—Palpitations—Dextrothyroxine—hypothyroidism	0.000782	0.00748	CcSEcCtD
Losartan—Palpitations—Levothyroxine—hypothyroidism	0.000782	0.00748	CcSEcCtD
Losartan—UGT2B7—liver—hypothyroidism	0.000766	0.0116	CbGeAlD
Losartan—Arthralgia—Dextrothyroxine—hypothyroidism	0.000753	0.00721	CcSEcCtD
Losartan—Arthralgia—Levothyroxine—hypothyroidism	0.000753	0.00721	CcSEcCtD
Losartan—ALB—heart—hypothyroidism	0.000752	0.0113	CbGeAlD
Losartan—Anxiety—Levothyroxine—hypothyroidism	0.000751	0.00718	CcSEcCtD
Losartan—Anxiety—Dextrothyroxine—hypothyroidism	0.000751	0.00718	CcSEcCtD
Losartan—Hypoaesthesia—Liotrix—hypothyroidism	0.000744	0.00712	CcSEcCtD
Losartan—Confusional state—Levothyroxine—hypothyroidism	0.000728	0.00697	CcSEcCtD
Losartan—Confusional state—Dextrothyroxine—hypothyroidism	0.000728	0.00697	CcSEcCtD
Losartan—AGTR1—adrenal gland—hypothyroidism	0.000727	0.011	CbGeAlD
Losartan—AGTR1—blood—hypothyroidism	0.000727	0.011	CbGeAlD
Losartan—ACE—heart—hypothyroidism	0.00072	0.0109	CbGeAlD
Losartan—Shock—Dextrothyroxine—hypothyroidism	0.00071	0.0068	CcSEcCtD
Losartan—Shock—Levothyroxine—hypothyroidism	0.00071	0.0068	CcSEcCtD
Losartan—Tachycardia—Levothyroxine—hypothyroidism	0.000705	0.00674	CcSEcCtD
Losartan—Tachycardia—Dextrothyroxine—hypothyroidism	0.000705	0.00674	CcSEcCtD
Losartan—AGTR1—thyroid gland—hypothyroidism	0.000702	0.0106	CbGeAlD
Losartan—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000698	0.00668	CcSEcCtD
Losartan—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000698	0.00668	CcSEcCtD
Losartan—Flushing—Liotrix—hypothyroidism	0.000694	0.00664	CcSEcCtD
Losartan—SLCO1B1—blood—hypothyroidism	0.000693	0.0105	CbGeAlD
Losartan—AGTR1—Arf6 trafficking events—TSHR—hypothyroidism	0.000688	0.0194	CbGpPWpGaD
Losartan—ACE—cardiovascular system—hypothyroidism	0.000679	0.0103	CbGeAlD
Losartan—Arrhythmia—Liotrix—hypothyroidism	0.000668	0.00639	CcSEcCtD
Losartan—Alopecia—Liotrix—hypothyroidism	0.000661	0.00632	CcSEcCtD
Losartan—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000658	0.00629	CcSEcCtD
Losartan—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000658	0.00629	CcSEcCtD
Losartan—Insomnia—Dextrothyroxine—hypothyroidism	0.000653	0.00625	CcSEcCtD
Losartan—Insomnia—Levothyroxine—hypothyroidism	0.000653	0.00625	CcSEcCtD
Losartan—UGT1A1—liver—hypothyroidism	0.000652	0.00984	CbGeAlD
Losartan—Dyspnoea—Levothyroxine—hypothyroidism	0.000644	0.00616	CcSEcCtD
Losartan—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000644	0.00616	CcSEcCtD
Losartan—ACE—Peptide hormone metabolism—TSHB—hypothyroidism	0.000642	0.0181	CbGpPWpGaD
Losartan—Flatulence—Liotrix—hypothyroidism	0.000641	0.00614	CcSEcCtD
Losartan—Tension—Liotrix—hypothyroidism	0.000639	0.00611	CcSEcCtD
Losartan—Dysgeusia—Liotrix—hypothyroidism	0.000637	0.0061	CcSEcCtD
Losartan—Nervousness—Liotrix—hypothyroidism	0.000632	0.00605	CcSEcCtD
Losartan—Fatigue—Levothyroxine—hypothyroidism	0.000623	0.00596	CcSEcCtD
Losartan—Fatigue—Dextrothyroxine—hypothyroidism	0.000623	0.00596	CcSEcCtD
Losartan—ACE—gonad—hypothyroidism	0.000616	0.0093	CbGeAlD
Losartan—Vision blurred—Liotrix—hypothyroidism	0.000613	0.00587	CcSEcCtD
Losartan—Tremor—Liotrix—hypothyroidism	0.00061	0.00583	CcSEcCtD
Losartan—AGTR1—testis—hypothyroidism	0.000601	0.00908	CbGeAlD
Losartan—ACE—pituitary gland—hypothyroidism	0.000601	0.00908	CbGeAlD
Losartan—Agitation—Liotrix—hypothyroidism	0.000598	0.00572	CcSEcCtD
Losartan—Feeling abnormal—Levothyroxine—hypothyroidism	0.000595	0.00569	CcSEcCtD
Losartan—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000595	0.00569	CcSEcCtD
Losartan—Angioedema—Liotrix—hypothyroidism	0.000595	0.00569	CcSEcCtD
Losartan—SLC2A9—NRF2 pathway—SLC5A5—hypothyroidism	0.000593	0.0167	CbGpPWpGaD
Losartan—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000591	0.00565	CcSEcCtD
Losartan—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000591	0.00565	CcSEcCtD
Losartan—Syncope—Liotrix—hypothyroidism	0.000584	0.00558	CcSEcCtD
Losartan—Palpitations—Liotrix—hypothyroidism	0.000575	0.0055	CcSEcCtD
Losartan—Urticaria—Levothyroxine—hypothyroidism	0.000574	0.00549	CcSEcCtD
Losartan—Urticaria—Dextrothyroxine—hypothyroidism	0.000574	0.00549	CcSEcCtD
Losartan—Loss of consciousness—Liotrix—hypothyroidism	0.000572	0.00547	CcSEcCtD
Losartan—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000571	0.00546	CcSEcCtD
Losartan—Abdominal pain—Levothyroxine—hypothyroidism	0.000571	0.00546	CcSEcCtD
Losartan—Body temperature increased—Levothyroxine—hypothyroidism	0.000571	0.00546	CcSEcCtD
Losartan—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000571	0.00546	CcSEcCtD
Losartan—AGTR1—liver—hypothyroidism	0.000569	0.00858	CbGeAlD
Losartan—ALB—adrenal gland—hypothyroidism	0.000561	0.00847	CbGeAlD
Losartan—Arthralgia—Liotrix—hypothyroidism	0.000554	0.0053	CcSEcCtD
Losartan—Chest pain—Liotrix—hypothyroidism	0.000554	0.0053	CcSEcCtD
Losartan—Anxiety—Liotrix—hypothyroidism	0.000552	0.00528	CcSEcCtD
Losartan—SLCO1B1—liver—hypothyroidism	0.000542	0.00819	CbGeAlD
Losartan—ACE—adrenal gland—hypothyroidism	0.000537	0.00811	CbGeAlD
Losartan—ACE—blood—hypothyroidism	0.000537	0.00811	CbGeAlD
Losartan—Confusional state—Liotrix—hypothyroidism	0.000536	0.00512	CcSEcCtD
Losartan—Anaphylactic shock—Liotrix—hypothyroidism	0.000531	0.00508	CcSEcCtD
Losartan—Oedema—Liotrix—hypothyroidism	0.000531	0.00508	CcSEcCtD
Losartan—Infection—Liotrix—hypothyroidism	0.000528	0.00505	CcSEcCtD
Losartan—Shock—Liotrix—hypothyroidism	0.000523	0.005	CcSEcCtD
Losartan—Tachycardia—Liotrix—hypothyroidism	0.000518	0.00496	CcSEcCtD
Losartan—ACE—thyroid gland—hypothyroidism	0.000518	0.00782	CbGeAlD
Losartan—Asthenia—Dextrothyroxine—hypothyroidism	0.000518	0.00496	CcSEcCtD
Losartan—Asthenia—Levothyroxine—hypothyroidism	0.000518	0.00496	CcSEcCtD
Losartan—Hyperhidrosis—Liotrix—hypothyroidism	0.000514	0.00491	CcSEcCtD
Losartan—Pruritus—Levothyroxine—hypothyroidism	0.000511	0.00489	CcSEcCtD
Losartan—Pruritus—Dextrothyroxine—hypothyroidism	0.000511	0.00489	CcSEcCtD
Losartan—Anorexia—Liotrix—hypothyroidism	0.000506	0.00484	CcSEcCtD
Losartan—ACE—female gonad—hypothyroidism	0.000501	0.00756	CbGeAlD
Losartan—Hypotension—Liotrix—hypothyroidism	0.000496	0.00475	CcSEcCtD
Losartan—Diarrhoea—Levothyroxine—hypothyroidism	0.000494	0.00473	CcSEcCtD
Losartan—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000494	0.00473	CcSEcCtD
Losartan—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000484	0.00463	CcSEcCtD
Losartan—UGT1A3—NRF2 pathway—SLC5A7—hypothyroidism	0.000482	0.0136	CbGpPWpGaD
Losartan—Insomnia—Liotrix—hypothyroidism	0.00048	0.0046	CcSEcCtD
Losartan—AGTR1—Peptide GPCRs—TSHR—hypothyroidism	0.000479	0.0135	CbGpPWpGaD
Losartan—Paraesthesia—Liotrix—hypothyroidism	0.000477	0.00456	CcSEcCtD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000475	0.0134	CbGpPWpGaD
Losartan—Dyspnoea—Liotrix—hypothyroidism	0.000474	0.00453	CcSEcCtD
Losartan—CYP2C9—heart—hypothyroidism	0.000469	0.00708	CbGeAlD
Losartan—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000465	0.0131	CbGpPWpGaD
Losartan—ALB—testis—hypothyroidism	0.000464	0.00701	CbGeAlD
Losartan—Decreased appetite—Liotrix—hypothyroidism	0.000462	0.00442	CcSEcCtD
Losartan—Vomiting—Dextrothyroxine—hypothyroidism	0.000459	0.00439	CcSEcCtD
Losartan—Vomiting—Levothyroxine—hypothyroidism	0.000459	0.00439	CcSEcCtD
Losartan—Fatigue—Liotrix—hypothyroidism	0.000458	0.00438	CcSEcCtD
Losartan—Rash—Levothyroxine—hypothyroidism	0.000455	0.00436	CcSEcCtD
Losartan—Rash—Dextrothyroxine—hypothyroidism	0.000455	0.00436	CcSEcCtD
Losartan—Dermatitis—Dextrothyroxine—hypothyroidism	0.000455	0.00435	CcSEcCtD
Losartan—Dermatitis—Levothyroxine—hypothyroidism	0.000455	0.00435	CcSEcCtD
Losartan—Constipation—Liotrix—hypothyroidism	0.000454	0.00435	CcSEcCtD
Losartan—Headache—Dextrothyroxine—hypothyroidism	0.000452	0.00433	CcSEcCtD
Losartan—Headache—Levothyroxine—hypothyroidism	0.000452	0.00433	CcSEcCtD
Losartan—CYP2C19—blood—hypothyroidism	0.000452	0.00682	CbGeAlD
Losartan—ACE—testis—hypothyroidism	0.000444	0.00671	CbGeAlD
Losartan—CYP2C9—cardiovascular system—hypothyroidism	0.000443	0.00669	CbGeAlD
Losartan—CYP2C8—pituitary gland—hypothyroidism	0.000441	0.00666	CbGeAlD
Losartan—ALB—liver—hypothyroidism	0.000439	0.00662	CbGeAlD
Losartan—Feeling abnormal—Liotrix—hypothyroidism	0.000438	0.00419	CcSEcCtD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000435	0.0122	CbGpPWpGaD
Losartan—Gastrointestinal pain—Liotrix—hypothyroidism	0.000434	0.00416	CcSEcCtD
Losartan—ALB—Transport of organic anions—AVP—hypothyroidism	0.000434	0.0122	CbGpPWpGaD
Losartan—Nausea—Dextrothyroxine—hypothyroidism	0.000429	0.0041	CcSEcCtD
Losartan—Nausea—Levothyroxine—hypothyroidism	0.000429	0.0041	CcSEcCtD
Losartan—UGT2B17—Metabolism—IYD—hypothyroidism	0.000424	0.0119	CbGpPWpGaD
Losartan—Urticaria—Liotrix—hypothyroidism	0.000422	0.00404	CcSEcCtD
Losartan—Body temperature increased—Liotrix—hypothyroidism	0.00042	0.00402	CcSEcCtD
Losartan—Abdominal pain—Liotrix—hypothyroidism	0.00042	0.00402	CcSEcCtD
Losartan—ACE—liver—hypothyroidism	0.00042	0.00634	CbGeAlD
Losartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000419	0.0118	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—SLC5A7—hypothyroidism	0.00041	0.0115	CbGpPWpGaD
Losartan—CYP2C8—blood—hypothyroidism	0.000394	0.00595	CbGeAlD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000394	0.0111	CbGpPWpGaD
Losartan—Hypersensitivity—Liotrix—hypothyroidism	0.000391	0.00374	CcSEcCtD
Losartan—Asthenia—Liotrix—hypothyroidism	0.000381	0.00365	CcSEcCtD
Losartan—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000377	0.0106	CbGpPWpGaD
Losartan—Pruritus—Liotrix—hypothyroidism	0.000376	0.0036	CcSEcCtD
Losartan—SLC2A9—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000374	0.0105	CbGpPWpGaD
Losartan—CYP1A2—blood—hypothyroidism	0.000369	0.00557	CbGeAlD
Losartan—Diarrhoea—Liotrix—hypothyroidism	0.000363	0.00348	CcSEcCtD
Losartan—UGT2B17—Metabolism—ATP5O—hypothyroidism	0.00036	0.0101	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00036	0.0101	CbGpPWpGaD
Losartan—UGT2B17—Biological oxidations—POMC—hypothyroidism	0.000359	0.0101	CbGpPWpGaD
Losartan—CYP1A2—thyroid gland—hypothyroidism	0.000356	0.00538	CbGeAlD
Losartan—CYP3A5—blood—hypothyroidism	0.000356	0.00537	CbGeAlD
Losartan—CYP2C19—liver—hypothyroidism	0.000353	0.00533	CbGeAlD
Losartan—Dizziness—Liotrix—hypothyroidism	0.000351	0.00336	CcSEcCtD
Losartan—CYP2C9—blood—hypothyroidism	0.00035	0.00529	CbGeAlD
Losartan—SLC22A12—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000342	0.00963	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—TPO—hypothyroidism	0.000339	0.00954	CbGpPWpGaD
Losartan—Vomiting—Liotrix—hypothyroidism	0.000338	0.00323	CcSEcCtD
Losartan—Rash—Liotrix—hypothyroidism	0.000335	0.0032	CcSEcCtD
Losartan—Dermatitis—Liotrix—hypothyroidism	0.000335	0.0032	CcSEcCtD
Losartan—UGT1A1—NRF2 pathway—SLC5A7—hypothyroidism	0.000333	0.00937	CbGpPWpGaD
Losartan—Headache—Liotrix—hypothyroidism	0.000333	0.00318	CcSEcCtD
Losartan—CYP3A5—female gonad—hypothyroidism	0.000332	0.00501	CbGeAlD
Losartan—CYP2C8—testis—hypothyroidism	0.000326	0.00492	CbGeAlD
Losartan—Nausea—Liotrix—hypothyroidism	0.000316	0.00302	CcSEcCtD
Losartan—CYP2C8—liver—hypothyroidism	0.000308	0.00465	CbGeAlD
Losartan—SLC2A9—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000294	0.00829	CbGpPWpGaD
Losartan—CYP1A2—liver—hypothyroidism	0.000288	0.00436	CbGeAlD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000286	0.00805	CbGpPWpGaD
Losartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000282	0.00793	CbGpPWpGaD
Losartan—CYP3A5—liver—hypothyroidism	0.000278	0.0042	CbGeAlD
Losartan—CYP2C9—liver—hypothyroidism	0.000274	0.00413	CbGeAlD
Losartan—SLC22A12—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000269	0.00758	CbGpPWpGaD
Losartan—CYP3A4—blood—hypothyroidism	0.000267	0.00403	CbGeAlD
Losartan—ABCB1—adrenal cortex—hypothyroidism	0.000262	0.00395	CbGeAlD
Losartan—AGTR1—G alpha (q) signalling events—TRH—hypothyroidism	0.000256	0.0072	CbGpPWpGaD
Losartan—ABCB1—heart—hypothyroidism	0.000253	0.00382	CbGeAlD
Losartan—AGTR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000252	0.00711	CbGpPWpGaD
Losartan—ACE—Peptide hormone metabolism—POMC—hypothyroidism	0.000251	0.00708	CbGpPWpGaD
Losartan—ACE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000242	0.00681	CbGpPWpGaD
Losartan—ABCB1—cardiovascular system—hypothyroidism	0.000239	0.00361	CbGeAlD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000237	0.00667	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000229	0.00644	CbGpPWpGaD
Losartan—ABCB1—gonad—hypothyroidism	0.000217	0.00327	CbGeAlD
Losartan—ABCB1—pituitary gland—hypothyroidism	0.000212	0.0032	CbGeAlD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000211	0.00595	CbGpPWpGaD
Losartan—CYP3A4—liver—hypothyroidism	0.000209	0.00315	CbGeAlD
Losartan—UGT1A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000193	0.00542	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000192	0.00541	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00019	0.00535	CbGpPWpGaD
Losartan—ABCB1—adrenal gland—hypothyroidism	0.000189	0.00285	CbGeAlD
Losartan—ABCB1—blood—hypothyroidism	0.000189	0.00285	CbGeAlD
Losartan—ABCB1—thyroid gland—hypothyroidism	0.000182	0.00275	CbGeAlD
Losartan—ABCB1—female gonad—hypothyroidism	0.000176	0.00266	CbGeAlD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000175	0.00493	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000174	0.00489	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000169	0.00477	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—SLC5A5—hypothyroidism	0.000164	0.00461	CbGpPWpGaD
Losartan—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000161	0.00453	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000159	0.00448	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—TSHB—hypothyroidism	0.000157	0.00442	CbGpPWpGaD
Losartan—ABCB1—testis—hypothyroidism	0.000156	0.00236	CbGeAlD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000151	0.00425	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000151	0.00425	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00015	0.00421	CbGpPWpGaD
Losartan—ABCB1—liver—hypothyroidism	0.000148	0.00223	CbGeAlD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000145	0.00409	CbGpPWpGaD
Losartan—ABCB1—cerebellum—hypothyroidism	0.000144	0.00218	CbGeAlD
Losartan—UGT2B17—Metabolism—PIK3C2A—hypothyroidism	0.00014	0.00394	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000137	0.00385	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—AVP—hypothyroidism	0.000134	0.00378	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—SLC5A5—hypothyroidism	0.000133	0.00374	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000133	0.00373	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—TRH—hypothyroidism	0.000129	0.00363	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—TSHB—hypothyroidism	0.000121	0.00341	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00012	0.00339	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00012	0.00338	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—SLC5A5—hypothyroidism	0.000117	0.00331	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—TSHB—hypothyroidism	0.000115	0.00323	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—TSHR—hypothyroidism	0.000115	0.00323	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000114	0.00322	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00011	0.00309	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000107	0.00302	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—IYD—hypothyroidism	0.000104	0.00293	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—IYD—hypothyroidism	9.83e-05	0.00277	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.77e-05	0.00275	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	9.1e-05	0.00256	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—hypothyroidism	9.01e-05	0.00253	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.9e-05	0.0025	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	8.9e-05	0.0025	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ATP5O—hypothyroidism	8.87e-05	0.00249	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—IYD—hypothyroidism	8.87e-05	0.00249	CbGpPWpGaD
Losartan—UGT1A3—Biological oxidations—POMC—hypothyroidism	8.84e-05	0.00249	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—POMC—hypothyroidism	8.81e-05	0.00248	CbGpPWpGaD
Losartan—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.62e-05	0.00243	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	8.45e-05	0.00238	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ATP5O—hypothyroidism	8.35e-05	0.00235	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TPO—hypothyroidism	8.34e-05	0.00235	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.1e-05	0.00228	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TPO—hypothyroidism	7.86e-05	0.00221	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	7.68e-05	0.00216	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ATP5O—hypothyroidism	7.54e-05	0.00212	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—POMC—hypothyroidism	7.51e-05	0.00211	CbGpPWpGaD
Losartan—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.47e-05	0.0021	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TRH—hypothyroidism	7.29e-05	0.00205	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.28e-05	0.00205	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—IYD—hypothyroidism	7.2e-05	0.00203	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TPO—hypothyroidism	7.09e-05	0.00199	CbGpPWpGaD
Losartan—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.99e-05	0.00197	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—AVP—hypothyroidism	6.78e-05	0.00191	CbGpPWpGaD
Losartan—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.66e-05	0.00188	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.65e-05	0.00187	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TRH—hypothyroidism	6.62e-05	0.00186	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—IYD—hypothyroidism	6.6e-05	0.00186	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TSHB—hypothyroidism	6.5e-05	0.00183	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—TSHR—hypothyroidism	6.5e-05	0.00183	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—POMC—hypothyroidism	6.15e-05	0.00173	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ATP5O—hypothyroidism	6.13e-05	0.00172	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—POMC—hypothyroidism	6.11e-05	0.00172	CbGpPWpGaD
Losartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.08e-05	0.00171	CbGpPWpGaD
Losartan—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.05e-05	0.0017	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.05e-05	0.0017	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.91e-05	0.00166	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TSHB—hypothyroidism	5.9e-05	0.00166	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TSHR—hypothyroidism	5.9e-05	0.00166	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.81e-05	0.00164	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TPO—hypothyroidism	5.76e-05	0.00162	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—IGF1—hypothyroidism	5.67e-05	0.0016	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ATP5O—hypothyroidism	5.61e-05	0.00158	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	5.58e-05	0.00157	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	5.4e-05	0.00152	CbGpPWpGaD
Losartan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.4e-05	0.00152	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TPO—hypothyroidism	5.28e-05	0.00149	CbGpPWpGaD
Losartan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.19e-05	0.00146	CbGpPWpGaD
Losartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.93e-05	0.00139	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	4.89e-05	0.00138	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.89e-05	0.00138	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—POMC—hypothyroidism	4.75e-05	0.00134	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.63e-05	0.0013	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—AVP—hypothyroidism	4.58e-05	0.00129	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—IGF1—hypothyroidism	4.57e-05	0.00128	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CLTC—hypothyroidism	4.52e-05	0.00127	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—POMC—hypothyroidism	4.5e-05	0.00127	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	4.39e-05	0.00124	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—IYD—hypothyroidism	4.38e-05	0.00123	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.29e-05	0.00121	CbGpPWpGaD
Losartan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.21e-05	0.00118	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	4.09e-05	0.00115	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.05e-05	0.00114	CbGpPWpGaD
Losartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.01e-05	0.00113	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—VAV3—hypothyroidism	3.97e-05	0.00112	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TRH—hypothyroidism	3.91e-05	0.0011	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.91e-05	0.0011	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TSHB—hypothyroidism	3.86e-05	0.00109	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AVP—hypothyroidism	3.83e-05	0.00108	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—IYD—hypothyroidism	3.79e-05	0.00107	CbGpPWpGaD
Losartan—ALB—Metabolism—IYD—hypothyroidism	3.77e-05	0.00106	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ATP5O—hypothyroidism	3.72e-05	0.00105	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—POMC—hypothyroidism	3.71e-05	0.00104	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TSHB—hypothyroidism	3.64e-05	0.00102	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—VAV3—hypothyroidism	3.61e-05	0.00102	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TPO—hypothyroidism	3.5e-05	0.000985	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TSHR—hypothyroidism	3.48e-05	0.000981	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TSHB—hypothyroidism	3.48e-05	0.000981	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AVP—hypothyroidism	3.48e-05	0.000978	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	3.46e-05	0.000973	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3C2A—hypothyroidism	3.44e-05	0.000968	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—IYD—hypothyroidism	3.39e-05	0.000953	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	3.38e-05	0.000951	CbGpPWpGaD
Losartan—ABCB1—Metabolism—IYD—hypothyroidism	3.3e-05	0.00093	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TSHB—hypothyroidism	3.28e-05	0.000923	CbGpPWpGaD
Losartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.25e-05	0.000914	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3C2A—hypothyroidism	3.24e-05	0.000912	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ATP5O—hypothyroidism	3.23e-05	0.000908	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—POMC—hypothyroidism	3.22e-05	0.000905	CbGpPWpGaD
Losartan—ALB—Metabolism—ATP5O—hypothyroidism	3.21e-05	0.000903	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.2e-05	0.0009	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SH2B3—hypothyroidism	3.11e-05	0.000874	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—IYD—hypothyroidism	3.09e-05	0.000869	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.07e-05	0.000865	CbGpPWpGaD
Losartan—ALB—Hemostasis—SH2B3—hypothyroidism	3.07e-05	0.000864	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TPO—hypothyroidism	3.03e-05	0.000853	CbGpPWpGaD
Losartan—ALB—Metabolism—TPO—hypothyroidism	3.02e-05	0.000849	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3C2A—hypothyroidism	2.92e-05	0.000823	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SLC5A5—hypothyroidism	2.89e-05	0.000813	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ATP5O—hypothyroidism	2.88e-05	0.00081	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—POMC—hypothyroidism	2.87e-05	0.000808	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ATP5O—hypothyroidism	2.81e-05	0.000791	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.81e-05	0.000791	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.79e-05	0.000786	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SLC5A5—hypothyroidism	2.72e-05	0.000766	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TPO—hypothyroidism	2.71e-05	0.000762	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TSHB—hypothyroidism	2.67e-05	0.00075	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TPO—hypothyroidism	2.64e-05	0.000744	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—IYD—hypothyroidism	2.64e-05	0.000742	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ATP5O—hypothyroidism	2.63e-05	0.000739	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—POMC—hypothyroidism	2.62e-05	0.000736	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—POMC—hypothyroidism	2.54e-05	0.000716	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.52e-05	0.000708	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.51e-05	0.000706	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.48e-05	0.000697	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TPO—hypothyroidism	2.47e-05	0.000695	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SLC5A5—hypothyroidism	2.46e-05	0.000691	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TSHB—hypothyroidism	2.44e-05	0.000688	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3C2A—hypothyroidism	2.38e-05	0.000669	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—POMC—hypothyroidism	2.31e-05	0.00065	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PRL—hypothyroidism	2.3e-05	0.000648	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.29e-05	0.000644	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ATP5O—hypothyroidism	2.24e-05	0.000631	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—POMC—hypothyroidism	2.24e-05	0.000629	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.23e-05	0.000628	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	2.18e-05	0.000613	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.15e-05	0.000605	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VAV3—hypothyroidism	2.13e-05	0.0006	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TPO—hypothyroidism	2.11e-05	0.000594	CbGpPWpGaD
Losartan—ALB—Hemostasis—VAV3—hypothyroidism	2.11e-05	0.000593	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AVP—hypothyroidism	2.05e-05	0.000578	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—IYD—hypothyroidism	2.04e-05	0.000573	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SLC5A5—hypothyroidism	2e-05	0.000562	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.95e-05	0.00055	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.95e-05	0.00055	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.83e-05	0.000515	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	1.76e-05	0.000494	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.73e-05	0.000487	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.73e-05	0.000486	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TPO—hypothyroidism	1.63e-05	0.000458	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TSHB—hypothyroidism	1.62e-05	0.000456	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.54e-05	0.000433	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—POMC—hypothyroidism	1.51e-05	0.000425	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.44e-05	0.000407	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—POMC—hypothyroidism	1.42e-05	0.000401	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TSHB—hypothyroidism	1.4e-05	0.000395	CbGpPWpGaD
Losartan—ALB—Metabolism—TSHB—hypothyroidism	1.4e-05	0.000393	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—POMC—hypothyroidism	1.36e-05	0.000384	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IGF1—hypothyroidism	1.31e-05	0.000369	CbGpPWpGaD
Losartan—ALB—Hemostasis—IGF1—hypothyroidism	1.3e-05	0.000365	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—POMC—hypothyroidism	1.29e-05	0.000362	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TSHB—hypothyroidism	1.25e-05	0.000353	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.25e-05	0.000352	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3C2A—hypothyroidism	1.24e-05	0.00035	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.23e-05	0.000347	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.23e-05	0.000345	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TSHB—hypothyroidism	1.22e-05	0.000344	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.21e-05	0.000341	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TSHB—hypothyroidism	1.14e-05	0.000322	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.12e-05	0.000314	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.1e-05	0.00031	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.09e-05	0.000307	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.05e-05	0.000296	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC5A5—hypothyroidism	1.05e-05	0.000294	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—POMC—hypothyroidism	1.04e-05	0.000294	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.02e-05	0.000287	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1e-05	0.000283	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TSHB—hypothyroidism	9.76e-06	0.000275	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—POMC—hypothyroidism	9.57e-06	0.000269	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC5A5—hypothyroidism	9.38e-06	0.000264	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC5A5—hypothyroidism	9.16e-06	0.000258	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	8.7e-06	0.000245	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.59e-06	0.000242	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC5A5—hypothyroidism	8.55e-06	0.000241	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TSHB—hypothyroidism	7.54e-06	0.000212	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A5—hypothyroidism	7.31e-06	0.000206	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	6.72e-06	0.000189	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—hypothyroidism	6.35e-06	0.000179	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A5—hypothyroidism	5.64e-06	0.000159	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—hypothyroidism	5.5e-06	0.000155	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—hypothyroidism	5.47e-06	0.000154	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—hypothyroidism	4.91e-06	0.000138	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—hypothyroidism	4.79e-06	0.000135	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—hypothyroidism	4.48e-06	0.000126	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—hypothyroidism	3.82e-06	0.000108	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—hypothyroidism	2.95e-06	8.31e-05	CbGpPWpGaD
